Reynolds Cameron John 4
4 · VOLITIONRX LTD · Filed Apr 15, 2020
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
Reynolds Cameron John
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2020-04-13+85,000→ 85,000 totalExercise: $3.60From: 2021-04-13Exp: 2026-04-13→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]A total of 85,000 Options were granted on April 13, 2020 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant.